Organon Makes Deal With Huya For Access To Chinese Drugs
This article was originally published in PharmAsia News
Executive Summary
Organon has signed a collaborative deal with Huya Bioscience, a San Diego-based company that promises to link the Dutch drug maker with the owners of new compounds being developed in China